Personal information

No personal information available

Activities

Collapse all

Employment (8)

klausrose Consulting : Basel, CH

2011 to 2014 | CEO
Employment
Source: Self-asserted source
Klaus Rose

Granzer Regulatory Consultancy: Munich, DE

2010 to 2011 | Principal Consultant
Employment
Source: Self-asserted source
Klaus Rose

F Hoffman La Roche Ltd: Basel, Basel-Stadt, CH

2005 to 2009 | Global Head Pediatrics (Development)
Employment
Source: Self-asserted source
Klaus Rose

Novartis Pharma AG: Basel, BS, CH

2001 to 2005 | Global Head Pediatrics (Development)
Employment
Source: Self-asserted source
Klaus Rose

Novartis Pharma AG: Basel, BS, CH

1999 to 2000 | Senior International Medical Advisor (Clinical Research & Development )
Employment
Source: Self-asserted source
Klaus Rose

Novartis: Bern, CH

1997 to 1999 | Clinical Research Physician
Employment
Source: Self-asserted source
Klaus Rose

Byk Gulden Pharma Switzerland : Kreuzlingen, CH

1991 to 1996 | Medical Director
Employment
Source: Self-asserted source
Klaus Rose

Byk Gulden Pharma: Konstanz, DE

1991 to 1996 | Clinical Research Physician (Clinical Research & Development)
Employment
Source: Self-asserted source
Klaus Rose

Education and qualifications (2)

Freie Universitat Berlin: Berlin, Berlin, DE

1979 to 1986 | M.D.
Education
Source: Self-asserted source
Klaus Rose

Technische Universität Berlin: Berlin, Berlin, DE

1972 to 1978 | M.S.
Education
Source: Self-asserted source
Klaus Rose

Works (3)

European UnionPediatric Legislation Jeopardizes Worldwide, Timely Future Advances in the Care of Children With Cancer

Clinical Therapeutics
2014 | Journal article
Contributors: Klaus Rose
Source: Self-asserted source
Klaus Rose

The Vision of Better Medicines for Children and the Role of Regulatory Authorities

Pharmaceutical Regulatory Affairs: Open Access
2014 | Journal article
Contributors: Klaus Rose
Source: Self-asserted source
Klaus Rose

Pediatric Epilepsy: Time For New Research Goals
Source: check_circle
Multidisciplinary Digital Publishing Institute

Peer review (7 reviews for 3 publications/grants)

Review activity for BMJ case reports. (1)
Review activity for Pharmaceutical medicine. (3)
Review activity for Therapeutic innovation & regulatory science. (3)
How many people are using ORCID?